These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34150640)

  • 1. High Expression of Cancer-IgG Is Associated With Poor Prognosis and Radioresistance
    Yang X; Wang G; You J; Gu R; Xu X; Xu C; Wang H; Zhao R; Qiu X; Zhu G
    Front Oncol; 2021; 11():675397. PubMed ID: 34150640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [TRIP13 Enhances Radioresistance of Lung Adenocarcinoma Cells 
through the Homologous Recombination Pathway].
    Ge S; Gu R; Yang X; Xu C; Wang S; Zhu G
    Zhongguo Fei Ai Za Zhi; 2024 Jan; 27(1):1-12. PubMed ID: 38296621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Golgi Phosphoprotein 3 Confers Radioresistance via Stabilizing EGFR in Lung Adenocarcinoma.
    Chen G; Kong P; Yang M; Hu W; Prise KM; Yu KN; Cui S; Qin F; Meng G; Almahi WA; Nie L; Han W
    Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1216-1228. PubMed ID: 34838866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High core 1β1,3-galactosyltransferase 1 expression is associated with poor prognosis and promotes cellular radioresistance in lung adenocarcinoma.
    Chen Y; Ji Y; Shen L; Li Y; Ren Y; Shi H; Li Y; Wu Y
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):214. PubMed ID: 38662050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knocking Down Nucleolin Expression Enhances the Radiosensitivity of Non-Small Cell Lung Cancer by Influencing DNA-PKcs Activity.
    Xu JY; Lu S; Xu XY; Hu SL; Li B; Qi RX; Chen L; Chang JY
    Asian Pac J Cancer Prev; 2015; 16(8):3301-6. PubMed ID: 25921135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COL3A1-positive endothelial cells influence LUAD prognosis and regulate LUAD carcinogenesis by NCL-PI3K-AKT axis.
    Zhang M; Liang Y; Song P
    J Gene Med; 2024 Jan; 26(1):e3573. PubMed ID: 37547956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
    Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Establishment of Human Lung Adenocarcinoma Radioresistant Cell Lines
and the Mechanism of Radioresistance].
    Zhang J; Ma S; Wu Q
    Zhongguo Fei Ai Za Zhi; 2023 Feb; 26(2):93-104. PubMed ID: 36872048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-dependent protein kinase catalytic subunit inhibitor reverses acquired radioresistance in lung adenocarcinoma by suppressing DNA repair.
    Li Y; Li H; Peng W; He XY; Huang M; Qiu D; Xue YB; Lu L
    Mol Med Rep; 2015 Jul; 12(1):1328-34. PubMed ID: 25815686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary: High Expression of Cancer-IgG Is Associated With Poor Prognosis and Radioresistance
    Yang L; Lu P; Qu S
    Front Oncol; 2021; 11():741089. PubMed ID: 34692521
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiosensitization and growth inhibition of cancer cells mediated by an scFv antibody gene against DNA-PKcs in vitro and in vivo.
    Du L; Zhou LJ; Pan XJ; Wang YX; Xu QZ; Yang ZH; Wang Y; Liu XD; Zhu MX; Zhou PK
    Radiat Oncol; 2010 Aug; 5():70. PubMed ID: 20704701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-101-3p sensitizes lung adenocarcinoma cells to irradiation via targeting BIRC5.
    Meng X; Sun Y; Liu S; Mu Y
    Oncol Lett; 2021 Apr; 21(4):282. PubMed ID: 33732358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma.
    Jiang X; Li Y; Zhang N; Gao Y; Han L; Li S; Li J; Liu X; Gong Y; Xie C
    Cell Biosci; 2021 Apr; 11(1):74. PubMed ID: 33858512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HSD17B6 downregulation predicts poor prognosis and drives tumor progression via activating Akt signaling pathway in lung adenocarcinoma.
    Tian T; Hong F; Wang Z; Hu J; Chen N; Lv L; Yi Q
    Cell Death Discov; 2021 Nov; 7(1):341. PubMed ID: 34750355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing LINC01116 suppresses the development of lung adenocarcinoma via the AKT signaling pathway.
    Shang B; Li Z; Li M; Jiang S; Feng Z; Cao Z; Wang H
    Thorac Cancer; 2021 Jul; 12(14):2093-2103. PubMed ID: 34061456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Methoxyestradiol-induced radiosensitization is independent of SOD but depends on inhibition of Akt and DNA-PKcs activities.
    Florczak U; Toulany M; Kehlbach R; Peter Rodemann H
    Radiother Oncol; 2009 Sep; 92(3):334-8. PubMed ID: 19589609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
    Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X
    Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual targeting of PI3K and MEK enhances the radiation response of K-RAS mutated non-small cell lung cancer.
    Toulany M; Iida M; Keinath S; Iyi FF; Mueck K; Fehrenbacher B; Mansour WY; Schaller M; Wheeler DL; Rodemann HP
    Oncotarget; 2016 Jul; 7(28):43746-43761. PubMed ID: 27248324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and mechanisms of radioresistant lung squamous cell carcinoma cell lines.
    Pan L; Wu Q; Wang Y; Ma S; Zhang S
    Thorac Cancer; 2023 May; 14(14):1239-1250. PubMed ID: 37028947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.